We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of STAB yet.

STAB Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q3 2023, worth a combined $0 — down 100% from $30 a quarter earlier.

Fund positioning in STAB was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Statera Biopharma, Inc. Common Stock (STAB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $0 of Statera Biopharma, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Statera Biopharma, Inc. Common Stock positions in Q3 2023 and 0 closed out.

Based on aggregated 13F filings for Q3 2023.